Avalo Therapeutics, Inc. current report, 23 April 2018

Business Context and Reporting Period

This Form 8-K is a current report filed by Cerecor Inc. (not Avalo Therapeutics, Inc.) on April 23, 2018. The filing discloses significant changes in executive leadership, specifically the appointment of a new Executive Vice President and the formalization of a separation agreement with a former executive.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on personnel compensation and separation terms.

Material Changes and Personnel Actions

Appointment of James A. Harrell, Jr.

  • Role: Executive Vice President, Marketing and External Communications.
  • Start Date: May 7, 2018.
  • Compensation:
    • Base Salary: $310,000 per year.
    • Equity: Option to purchase 125,000 shares of common stock, vesting over four years.
    • Bonus: Discretionary annual bonus with a target of 40% of base salary.
  • Termination Benefits: In the event of termination without "Cause" or resignation for "Good Reason," Mr. Harrell is eligible for 12 months of continued base salary, prorated bonus, full vesting of options, and COBRA premium coverage for up to one year.

Separation of Robert Moscato

  • Former Role: President and Chief Operating Officer.
  • Separation Date: Effective March 27, 2018.
  • Agreement Date: April 23, 2018.
  • Compensation:
    • Continued base salary payments for eight months from the Separation Date.
    • COBRA premium payments for the lesser of eight months or until eligibility for equivalent insurance.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, outlook, or general risk factors. The primary contingencies relate to the specific terms of the employment and separation agreements, including non-competition (six months) and non-solicitation (one year) covenants applicable to Mr. Harrell post-employment.

Investor Verification Checklist

  • Verify the exact terms of the 125,000 stock options granted to James A. Harrell, Jr. by reviewing Exhibit 10.1.
  • Confirm the total cash outflow for Robert Moscato's separation package (8 months of salary) against the company's current cash position.
  • Review the definitions of "Cause" and "Good Reason" in the employment agreement to understand the triggers for accelerated vesting and severance.
  • Check subsequent filings for any updates on the company's cash runway given the new executive compensation commitments.